CRH Medical Corp (TSE:CRH) had its price objective hoisted by analysts at Royal Bank Of Canada from C$7.00 to C$8.50 in a report issued on Monday. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 1.67% from the company’s current price.

CRH has been the topic of several other reports. Bloom Burton reissued a “buy” rating on shares of CRH Medical Corp in a research report on Friday, October 28th. CIBC reissued an “outperform” rating on shares of CRH Medical Corp in a research report on Tuesday, September 13th. Finally, RBC Capital Markets set a C$6.50 price objective on shares of CRH Medical Corp and gave the company an “outperform” rating in a research report on Thursday, October 6th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. CRH Medical Corp currently has an average rating of “Buy” and an average price target of C$6.90.

Analyst Recommendations for CRH Medical Corp (TSE:CRH)

CRH Medical Corp (TSE:CRH) traded down 9.09% during trading on Monday, reaching $7.60. 794,781 shares of the company’s stock were exchanged. The stock’s 50 day moving average price is $6.74 and its 200 day moving average price is $5.26. The firm has a market cap of $549.68 million and a P/E ratio of 77.55. CRH Medical Corp has a 52-week low of $2.98 and a 52-week high of $8.48.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The original version of this news story can be read at

Receive News & Stock Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related stocks with our FREE daily email newsletter.